Observational analysis identifies prognostic factors for favorable responses to immunotherapy in advanced HNSCC, indicating tailored treatment possibilities.
Background Locally advanced unresectable or metastatic head and neck squamous cell carcinoma carries a poor prognosis with limited palliative systemic treatment options. We sought to evaluate clinic-pathological characteristics associated with favorable responses to palliative-intent immunotherapy.
No takes yet. Share an insight, caveat, or question.
Maqrashi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: